Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Nanotim Corp (417010:KRX), powered by AI.
Nanotim Corp is currently trading at ₩11,940. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Nanotim Corp on Alpha Lenz.
Nanotim Corp's P/E ratio is -63.2.
“Nanotim Corp trades at a P/E of -63.2 (undervalued) with modest ROE of -7.8%.”
Ask for details →Nanotim Corp is a prominent player in the healthcare technology industry, specializing in the development and manufacture of nanotechnology-based medical devices. The primary purpose of the company is to innovate and deliver cutting-edge solutions that enhance diagnostic accuracy and treatment efficacy. Nanotim Corp's offerings are pivotal in elevating the standards of patient care, making breakthroughs in how diseases are detected and managed at the microscopic level. The company's portfolio includes nanoscale imaging devices and advanced biosensors, serving crucial functions in clinical laboratories and research institutions. As a pioneer in its field, Nanotim Corp impacts sectors such as cancer treatment, genomic studies, and personalized medicine. Its market significance is underscored by its commitment to pushing the boundaries of medical technology, fostering advancements that propel healthcare into a new era of precision and personalized care. Established with a focus on sustainability and innovation, Nanotim Corp continues to drive progress in healthcare by melding the realms of nanotechnology and medical science.
“Nanotim Corp trades at a P/E of -63.2 (undervalued) with modest ROE of -7.8%.”
Ask for details →Nanotim Corp (ticker: 417010) is a company listed on KRX in the Technology sector (Electronic Components). It has approximately 102 employees. Market cap is $240.9B.
The current price is ₩11,940 with a P/E ratio of -63.22x and P/B of 5.24x.
ROE is -7.84% and operating margin is -11.62%. Annual revenue is $32.4B.